Intracellular phosphorylation of chloro-adenosine analogs is a prerequisite for activation of caspase-3 and induction of apoptosis in human astrocytoma cells

Drug Development Research

Volumn 58, Issue 4, 2003, Pages 396-404

  Ceruti, Stefania ^a   Mazzola, Alessia ^a   Beltrami, Elena ^a   Passera, Davide ^a   Piantoni, Elena ^a   Cattabeni, Flaminio ^a   Abbracchio, Maria P ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

2 chloro adenosine; Cell death; Central nervous system tumors; Cladribine; Nucleotide kinases

Indexed keywords

2 CHLOROADENOSINE; 5 IODOTUBERCIDIN; ADENOSINE DERIVATIVE; CASPASE 3; CLADRIBINE; DEOXYCYTIDINE; NUCLEOTIDE DERIVATIVE; PRODRUG;

APOPTOSIS; ASTROCYTOMA CELL; CENTRAL NERVOUS SYSTEM TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PHOSPHORYLATION; TIME;

EID: 0038624563     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10184     Document Type: Conference Paper

References (33)

1. Abbracchio MP, Ceruti S, Barbieri D, Franceschi C, Malorni W, Biondo L, Burnstock G, Cattabeni F. 1995. A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem Biophys Res Commun 213:908-915.
2. Arner ESJ, Eriksson S. 1995. Mammalian deoxyribonucleoside kinase. Pharmacol Ther 2:155-186.
3. Barbieri D, Abbracchio MP, Salvioli S, Monti D, Cossarizza A, Ceruti S, Brambilla R, Cattabeni F, Jacobson KA, Franceschi C. 1998. Apoptosis by 2-chloro-2©-deoxy-adenosine and 2-chloroa-denosine in human peripheral blood mononuclear cells. Neurochem Int 32:493-504.
4. Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Bryson HM, Sorkin EM. 1993. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haemathological malignancies. Drugs 46:872-894.
6. Ceruti S, Barbieri D, Veronese E, Cattabeni F, Cossarizza A, Giammarioli AM, Malorni W, Franceschi C, Abbracchio MP. 1997. Different pathways of apoptosis revealed by 2-chloro-adenosine and deoxy-D-ribose in mammalian astroglial cells. J Neurosci Res 47:372-383.
7. Ceruti S, Giammarioli AM, Camurri A, Falzano L, Rufini S, Frank C, Fiorentini C, Malorni W, Abbracchio MP. 2000a. Adenosine-and 2-chloro-adenosine-induced cytopathic effects on myoblastic cells and myotubes: involvement of different intracellular mechanisms. Neuromusc Dis 10:436-446.
8. Ceruti S, Franceschi C, Barbieri D, Malorni W, Camurri A, Giammarioli AM, Ambrosini A, Racagni G, Cattabeni F, Abbracchio MP. 2000b. Apoptosis induced by 2-chloro-adenosine and 2-chloro-2′-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance. J Neurosci Res 60:388-400.
9. Ceruti S, Beltrami E, Matarrese P, Mazzola A, Cattabeni F, Malorni W, Abbracchio MP. 2003. A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2′-deoxy-adenosine (cladri-bine) and 2-chloro-adenosine in human astrocytoma cells. Mol Pharm, in press.
10. Earnshaw WC, Martins LM, Kaufmann SH. 1999. Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 68:383-424.
11. Galmarini CM, Mackey JR, Dumontet C. 2001. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 15:875-890.
12. Geiger JD, Parkinson F, Kowaluk E. 1997. Regulators of endogenous adenosine levels as therapeutic agents. In: Jacobson KA, Jarvis M, editors. Purinergic approaches in experimental therapeutics. New York: Wiley-Liss, p 55-84.
13. Genini D, Adachi S, Chao Q, Rose DW, Carrera CJ, Cottam HB, Carson DA, Leoni LM. 2000a. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. Blood 96:3537-3543.
14. Genini D, Budihardjo I, Plunkett W, Wang X, Carrera CJ, Cottam HB, Carson DA, Leoni LM. 2000b. Nucleotide requirement for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway. J Biol Chem 275:29-34.
15. Graziadei I, Kelly T, Schirmer M, Geisen FH, Vogel W, Konwalinka G. 1998. Antitumor effect of the nucleoside analogs 2-chloro-deoxyadenosine and 2, 2′-difluorodeoxycytidine on human hepatoma HepG2 cells. J Hepatol 28:504-509.
16. Hengstschlagher M, Pfeilstocker M, Wawra E. 1998. Thymidine kinase expression. A marker for malignant cells. In: Griesmacher et al., editors. Purine and pyrimidine metabolism in man IX. New York: Plenum Press. p 455-460.
17. Hentosh P, Tibudan M. 1995. In vitro transcription of DNA containing 2-chloro-2′-deoxyadenosine monophosphate. Mol Pharmacol 48:897-904.
18. Jacobson KA, Hoffmann C, Cattabeni F, Abbracchio MP. 1999. Adenosine-induced cell death: evidence for receptor-mediated signalling. Apoptosis 4:197-211.
19. Johnstone R, Ruefli AA, Lowe SW. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153-164.
20. Kaufmann SH, Earnshaw WC. 2000. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256:42-49.
21. Kawasaki H, Carrera CJ, Piro LD, Saven A, Kipps TJ, Carson DA. 1993. Relationship of deoxycytidine kinase and 5′-nucleotidase to the chemo-therapeutic efficacy of 2-chlorodeoxyadenosine. Blood 81:597-601.
22. Kleihues P, Soylemezoglu F, Schauble BW, Burger PC. 1995. Histopathology, classification and grading of gliomas. Glia 15:211-221.
23. 3 receptors agonists. Biochem Biophys Res Commun 219:904-910.
24. Lauria F, Rondelli D, Zinzani PL, Bocchia M, Marotta G, Salvucci M, Raspadori D, Ventura MA, Birtolo S, Forconi F, Tura S. 1997. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5 years survey. Leukemia 11:629-632.
25. Leoni LM, Chao Q, Cottam HB, Genini D, Rosenbach M, Carrera CJ, Budihardjo I, Wang X, Carson DA. 1998. Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c. Proc Natl Acad Sci USA 95:9567-9571.
26. Nomura Y, Inanami O, Takahashi K, Matsuda A, Kuwabara M. 2000. 2-Chloro-2′-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4. Leukemia 14:299-306.
27. Plunkett W, Saunders PP. 1991. Metabolism and action of purine nucleoside analogs. Pharmacol Ther 49:239-268.
28. Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA. 1985. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 75:377-383.
29. Spasokoukotskaja T, Sasvari-Szekely M, Hullan L, Albertioni F, Eriksson S, Staub M. 1998. Activation of deoxycytidine kinase by various nucleoside analogues. In: Griesmacher et al., editors. Purine and pyrimidine metabolism in man IX. New York: Plenum Press. p 641-645.
30. Szondy Z. 1995. The 2-chloro-deoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloro-adenosine. Biochem J 311:585-588.
31. Tallman MS, Hakimian D. 1995. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood 86:2463-2474.
32. Weber G, Singhal RL, Abonyi M, Prajda N, Hata Y, Yeh A, Look KY. 1993. Regulation of deoxycytidine kinase activity and inhibition by DFDC. Adv Enzyme Regul 33:39-59.
33. Wyczechowska D, Fabianowska-Majewska K. 1998. Does 2-chlorodeoxyadenosine contribute to alteration of DNA methyl-transferase activity? In: Griesmacher et al., editors. Purine and pyrimidine metabolism in man IX. New York: Plenum Press. p 595-598.